Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001019056-23-000205
Filing Date
2023-04-14
Accepted
2023-04-14 11:30:38
Documents
1
Period of Report
2023-04-03

Document Format Files

Seq Description Document Type Size
1 balasubramanian.html 3  
1 balasubramanian.xml 3 3586
  Complete submission text file 0001019056-23-000205.txt   4884
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 228 VILLAGE POND ROAD GUILFORD CT 06437
Business Address
Balasubramanian Suganthi (Reporting) CIK: 0001973629 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38410 | Film No.: 23820266